Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Diagnostics & Biomarkers - Online Event

Philipp Schatz's Biography

Philipp Schatz, Head of Biomarker Program, Metanomics Health GmbH

Philipp Schatz, Ph.D., is Head of Biomarker Program at Metanomics Health GmbH, a BASF Group Company, since 2012. Dr. Schatz has an in-depth understanding of biomarker discovery & validation, assay development, and commercialization. He oversees the Biomarker Program which provides metabolic biomarkers to support pharma-enabling and diagnostic applications in various indications such as, congestive heart failure, type 2 diabetes, neurodegenerative diseases and multiple oncological applications. Prior to Metanomics Health, Dr. Schatz worked for 12 years in the diagnostic industry. Dr. Schatz holds a M. Sc. in Biotechnology Engineering from the Technical University Berlin and a Ph.D. in epigenetics from the University of Saarland.

Philipp Schatz Image

New Metabolomics Biomarker for Heart Failure

Wednesday, 28 January 2015 at 10:00

Add to Calendar ▼2015-01-28 10:00:002015-01-28 11:00:00Europe/LondonNew Metabolomics Biomarker for Heart FailureDiagnostics and Biomarkers - Online Event in

The new blood plasma based CLIA-ready assay enables early HFrEF management in primary care settings. Due to its high clinical performance for the early diagnosis of HFrEF, this test offers a reliable and cost effective screening tool applicable to the primary care physician practice.

Add to Calendar ▼2015-01-27 00:00:002015-01-28 00:00:00Europe/LondonDiagnostics and Biomarkers - Online EventDiagnostics and Biomarkers - Online Event in